Boehringer Ingelheim International Gmbh

Ernst Kuechler

Dieter Blaas

Christoph Neubauer

Harald Mischak

Ingrid Maurer-Fogy

Timothy Skern

Wolfgang Sommergruber

Heinrich Kowalski

Markus Duechler

Peter Volkmann

Manfred Zorn

Peter Pallai

Friederike Fessl

A substantially pure receptor with binding activity for rhinoviruses of the minor human receptor group is disclosed, which has the following characteristics:

Receptor of the minor human rhinovirus receptor group

A substantially pure receptor with binding activity for rhinoviruses of the small receptor group is disclosed, which has the following characteristics:

Receptor of the small rhinovirus receptor group

Receptor for the human rhinovirus minor group

This invention relates to a DNA molecule or a functional derivative thereof coding for a fusion protein, the fusion protein comprising an enzymatically active component and a non-enzymatically active polypeptide component which may be cleaved therefrom, an expression system which contains the DNA molecule, the use thereof as a test system for inhibitors of viral proteases, and an assay for identifying viral inhibitors.

Expression of the virally coded protease P2A of HRV2

Growing community of inventors

Vienna, Austria

Ernst Kuechler